RICHARDSON ATTORNEYS AT LAW |
June 14, 2018
Via Edgar
Mail Stop 4546
Ms. Mary Beth Breslin
Assistant Director
Securities and Exchange Commission
Washington, D.C. 20549
| Re: | Med-X, Inc. |
|
| Offering Statement on Form 1-A – Post Qualification Amendment Number 5 Filed on May 16, 2018 Originally Filed August 27, 2015 File No. 024-10472 |
Dear Ms. Breslin:
Enclosed for filing on behalf of Med-X, Inc. is Amendment Number Six to the Offering Statement on Form 1-A originally filed with the Securities and Exchange Commission on August 27, 2015. The following is our response to the comments in your correspondence to us, dated June 11, 2018, regarding the above referenced filing on Form 1-A for Med-X, Inc.:
Summary of Risk Factors, page 1
We have added an additional bullet point to the Summary of Risk Factors on page one of the Offering Circular to highlight the fact that our Chairman, President and Chief Operating Officer, Matthew Mills, holds approximately 58% of the total shareholder voting power and can control the outcome of any matter submitted to a shareholder vote.
Principal Shareholders, page 42
We have revised the Principal Shareholders section of the Offering Circular to provide disclosure required by Item 12 of Form 1-A of Regulation A with respect to the Series A Preferred Stock issued by Med-X, Inc.
We respectfully request that the Securities and Exchange Commission qualify our Offering Statement on Monday, June 25, 2018, at 1:00pm Eastern Daylight Time.
| Very truly yours, | ||
 | ||
| Mark J. Richardson, Esq. |
| Cc: | Matthew Mills, President |
| Ronald Tchorzewski, Chief Financial Officer |
1453 THIRD STREET PROMENADE, SUITE 315, SANTA MONICA, CALIFORNIA 90401
TELEPHONE (310) 393-9992 FACSIMILE (310) 393-2004